Jewish & World News

The new flu vaccine for the upcoming 2012-2013 influenza season has been approved by The Food and Drug Administration. Each year the FDA works with the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to design a vaccine to protect against the three viral strains most likely to cause the flu in the upcoming year. This year's vaccine has one strain in common with last year's vaccine, plus two new viral strains its targeting.

An older version of the whooping cough vaccine offered better protection against the disease than the current version does, a new study from Australia suggests. Children who received the older version of the vaccine were less likely to catch the disease before age 12, compared with those who received the newer version of the vaccine, or a combination of the two vaccines, the study found.

Scheduling infant immunizations in the afternoon may lead to an increase in the infant's sleep over the next 24 hours. A new study shows that infants who received their vaccinations after 1:30 p.m. were more likely to sleep longer and have a small increase in body temperature in the 24 hours following vaccination.